Skip to content

Safety Study of Shenmai(a Chinese Medicine Injection) Used in Hospitals in China

A Registry Study on Safety Surveillance of Shenmai (a Chinese Medicine Injection) Used in China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01612611
Enrollment
30000
Registered
2012-06-06
Start date
2012-01-31
Completion date
2015-12-31
Last updated
2012-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease, Shock

Brief summary

The purpose of this study is to make a cohort event monitoring to see whether and how Shenmai injection in hospital results in adverse events or adverse drug reactions.

Detailed description

Safety surveillance on Chinese Medicine injection is an important problem that needs to be sorted out ,because in mainland China hospitals ,Chinese Medicine Injection are used widely. Population for taking medicine characteristics,the incidence rate of ADR and other uncertain factors influence can not be found now. A registry study for shenmai injection safety surveillance with 30000 patients will be conducted from Jan.2012 to Dec.2015. Eligibility criteria Patients who will use shenmai injection in selected hospitals.

Interventions

None listed

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
CollaboratorOTHER
China Academy of Chinese Medical Sciences
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* all inpatients use Shenmai injection in 30 selected hospitals during their hospital stay

Exclusion criteria

* none

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026